Trends in cervical cancer incidence in younger US women from 2000 to 2013

Gynecologic Oncology

Volumn 144, Issue 2, 2017, Pages 391-395

  Beachler, Daniel C ^a   Tota, Joseph E ^a   Silver, Michelle I ^a   Kreimer, Aimée R ^a   Hildesheim, Allan ^a   Wentzensen, Nicolas ^a   Schiffman, Mark ^a   Shiels, Meredith S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical cancer; Epidemiology; Pap test; Screening; SEER

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; FEMALE; HUMAN; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; CANCER REGISTRY; DELAYED DIAGNOSIS; INCIDENCE; TIME FACTOR; TRENDS; UTERINE CERVICAL NEOPLASMS;

ADULT; DELAYED DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; PAPANICOLAOU TEST; SEER PROGRAM; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 85007349352     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.11.031     Document Type: Article

References (27)

1. [1] Waxman, A.G., Guidelines for cervical cancer screening: history and scientific rationale. Clin. Obstet. Gynecol. 48 (Mar. 2005), 77–97.
2. [2] ACOG Committee, On practice bulletins–gynecology. ACOG practice bulletin no. 109: cervical cytology screening. Obstet. Gynecol. 114 (Dec 2009), 1409–1420.
3. [3] Ressel, G.W., American College of Obstetricians and Gynecologists. ACOG releases guidelines on cervical cytology screening. Am. Fam. Physician 15:68 (Nov 2003), 2081–2084.
4. [4] Moyer, V.A., U.S. preventive services task force. Screening for cervical cancer: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 19:156 (Jun 2012), 880–891 (W312).
5. [5] Saslow, D., Solomon, D., Lawson, H.W., Killackey, M., Kulasingam, S.L., Cain, J., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am. J. Clin. Pathol. 137 (2012 Apr), 516–542.
6. [6] Cervical Cancer Screening Among Women Aged 18–30 Years - United States, 2000–2010. Morb. Mortal. Wkly Rep., 61, 2013, 1038–1042.
7. [7] Boone, E., Lewis, L., Karp, M., Discontent and Confusion: Primary Care Providers' Opinions and Understanding of Current Cervical Cancer Screening Recommendations. J. Women's Health, Nov. 2015, 5 (Larchmt).
8. [8] Kurdgelashvili, G., Dores, G.M., Srour, S.A., Chaturvedi, A.K., Huycke, M.M., Devesa, S.S., Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007. Cancer 119 (Jun 15 2013), 2291–2299.
9. [9] Warren, J.L., Klabunde, C.N., Schrag, D., Bach, P.B., Riley, G.F., Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med. Care 40:IV (Aug 2002), 3–18.
10. [10] Site Recode ICD-O-3/WHO, Definition. http://seer.cancer.gov/siterecode/icdo3_dwhoheme/, 2008.
11. [11] Young, J.L., Roffers, S.D., LAG, R., Fritz, A.G., Hurlbut, A.A., (eds.) SEER Summary Staging Manual - 2000: Codes and Coding Instructions, 2001.
12. [12] Egevad, L., Heanue, M., Berney, D., Fleming, K., Ferlay, J., Chapter 4: Histological groups. Curado, M.P., Edwards, B., Shin, H.R., (eds.) Cancer Incidence in five Continents, Vol. IX, nineth ed., 2014, IARC Scientific Publications, Lyon, France, 61–66.
13. [13] BRFSS, CDC's Behavioral Risk Factor Surveillance System, Data User Guide. http://www.cdc.gov/brfss/.
14. [14] Tiro, J.A., Saraiya, M., Jain, N., Liddon, N., Cokkinides, V., Lai, S.M., et al. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer 113 (Nov 15 2008), 3013–3030.
15. [15] Pierannunzi, C., Hu, S.S., Balluz, L., A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004–2011. BMC Med. Res. Methodol. 13:49–2288 (Mar 24 2013), 13–49.
16. [16] Kim, H.J., Fay, M.P., Feuer, E.J., Midthune, D.N., Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19 (Feb 15 2000), 335–351.
17. [17] Saslow, D., Runowicz, C.D., Solomon, D., Moscicki, A.B., Smith, R.A., Eyre, H.J., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer. J. Clin. 52 (Nov–Dec 2002), 342–362.
18. [18] Roland, K.B., Benard, V.B., Soman, A., Breen, N., Kepka, D., Saraiya, M., Cervical cancer screening among young adult women in the United States. Cancer Epidemiol. Biomark. Prev. 22 (Apr 2013), 580–588.
19. [19] Cuzick, J., Myers, O., Hunt, W.C., Robertson, M., Joste, N.E., Castle, P.E., et al. A population-based evaluation of cervical screening in the United States: 2008–2011. Cancer Epidemiol. Biomark. Prev. 23 (May 2014), 765–773.
20. [20] Williams, W.W., Lu, P.J., O'Halloran, A., Bridges, C.B., Pilishvili, T., Hales, C.M., et al. Noninfluenza vaccination coverage among adults - United States, 2012. MMWR Morb. Mortal. Wkly. Rep. 63 (Feb 7 2014), 95–102.
21. [21] FUTURE II Study Group, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med. 356 (May 10 2007), 1915–1927.
22. [22] Herrero, R., Wacholder, S., Rodriguez, A.C., Solomon, D., Gonzalez, P., Kreimer, A.R., et al. Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer. Discov. 1 (Oct 2011), 408–419.
23. [23] Hildesheim, A., Gonzalez, P., Kreimer, A.R., Wacholder, S., Schussler, J., Rodriguez, A.C., et al. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am. J. Obstet. Gynecol., Feb 15 2016.
24. [24] Schiffman, M., Castle, P.E., Jeronimo, J., Rodriguez, A.C., Wacholder, S., Human papillomavirus and cervical cancer. Lancet 370 (Sep 8 2007), 890–907.
25. [25] Vink, M.A., Bogaards, J.A., van Kemenade, F.J., de Melker, H.E., Meijer, C.J., Berkhof, J., Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am. J. Epidemiol. 178 (Oct 1 2013), 1161–1169.
26. [26] Martinez, G.M., Abma, J.C., Sexual activity, contraceptive use, and childbearing of teenagers aged 15–19 in the United States. NCHS Data Brief 209 (Jul 2015), 1–8.
27. [27] Finkelhor, F., Jones, L., Shattuck, A., Updated Trends in Child Maltreatment. 2011, Crimes against Children Research Center, 2013.